🔎 Trials Near Me

ホーム › 2型糖尿病 › テキサス › Dallas

Dallas、TXにおける2型糖尿病の臨床試験

Dallasとその周辺地域(約30マイル以内)の拠点で、2型糖尿病に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト(英語)

ここで研究参加者を募集していますか? このページの上部に表示できます — 30日間 $99 →

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

被験者募集中第3相
  • North Texas Endocrine Center, Dallas
18歳以上 · 全性別 · 2026/09/30更新 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

被験者募集中第3相
  • Soltero Cardiovascular Research Center, Dallas
  • North Texas Endocrine Center, Dallas
  • Southwest Family Medicine Associates, Dallas
  • 他1件
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

被験者募集中第3相
  • University of Texas Southwestern Medical Center, Dallas
18歳以上 · 全性別 · 2026/09/30更新 · NCT07754461

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study

被験者募集中
  • University of Texas Southwestern Medical Center, Dallas
  • Parkland Health & Hospital System (PHHS), Dallas
  • Baylor Scott and White - Health System, Dallas
全年齢 · 全性別 · 2026/09/29更新 · NCT06593327

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

被験者募集中第3相
  • Velocity Clinical Research, Dallas, Dallas
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

被験者募集中第2相
  • M3 Wake Research - Dallas, Dallas
  • University of Texas Southwestern Medical Center, Dallas
18歳〜75歳 · 全性別 · 2026/09/15更新 · NCT07340320

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

被験者募集中第3相
  • Velocity Clinical Research, Dallas
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

被験者募集中第2相
  • University of Texas Southwestern Medical Center, Dallas
18歳〜75歳 · 全性別 · 2026/09/11更新 · NCT07415954

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

被験者募集中第2相
  • M3 Wake Research Dallas - Internal Medicine, Dallas
  • Revival Research Institute, LLC, Dallas
18歳〜80歳 · 全性別 · 2026/09/11更新 · NCT07271186

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

被験者募集中第2相
  • Velocity Clinical Research - Dallas, Dallas
18歳以上 · 全性別 · 2026/09/09更新 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

被験者募集中第2相
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT07215559

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

被験者募集中第3相
  • Research Site, Dallas
18歳以上 · 全性別 · 2026/08/31更新 · NCT07662109

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

被験者募集中第3相
  • Research Institute of Dallas, Dallas
10歳〜17歳 · 全性別 · 2026/08/07更新 · NCT06739122

Polypill for Prevention of Cardiomyopathy

被験者募集中第1/2相
  • UT Southwestern Medical Center, Dallas
18歳〜100歳 · 全性別 · 2026/08/04更新 · NCT06143566

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

被験者募集中第2相
  • Zenos Clinical Research, Dallas
18歳〜70歳 · 全性別 · 2026/06/15更新 · NCT07502508

HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes

被験者募集中第2相
  • Velocity Clinical Research Dallas, Dallas
18歳以上 · 全性別 · 2026/04/23更新 · NCT07546929

Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

被験者募集中
  • UT Southwestern Medical Center, Dallas
18歳〜60歳 · 全性別 · 2026/02/10更新 · NCT05168605

他の都市における2型糖尿病の試験

Dallasにおける他の研究

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。